143 related articles for article (PubMed ID: 18203259)
1. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
2. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.
Wu CC; Huang YS; Lee LY; Liang Y; Tang RP; Chang YS; Hsieh LL; Yu JS
Proteomics Clin Appl; 2008 Dec; 2(12):1586-95. PubMed ID: 21136809
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
5. Characterization of de novo synthesized proteins released from human colorectal tumour explants.
Shi HJ; Stubbs R; Hood K
Electrophoresis; 2009 Jul; 30(14):2442-53. PubMed ID: 19639566
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatic-metastasis risk of colorectal cancer upon the protein signature of PI3K/AKT pathway.
Kang B; Hao C; Wang H; Zhang J; Xing R; Shao J; Li W; Xu N; Lu Y; Liu S
J Proteome Res; 2008 Aug; 7(8):3507-15. PubMed ID: 18570457
[TBL] [Abstract][Full Text] [Related]
7. [Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].
Chen Y; Zhang H; Xu AJ; Liu JF; Li N; Wu SS; Huang LY; He DC; Xiao XY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):577-81. PubMed ID: 17988549
[TBL] [Abstract][Full Text] [Related]
8. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
10. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
11. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
[TBL] [Abstract][Full Text] [Related]
12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
13. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility.
Weng LP; Wu CC; Hsu BL; Chi LM; Liang Y; Tseng CP; Hsieh LL; Yu JS
J Proteome Res; 2008 Sep; 7(9):3765-75. PubMed ID: 18646789
[TBL] [Abstract][Full Text] [Related]
14. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
15. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.
Chen Y; Zhang H; Xu A; Li N; Liu J; Liu C; Lv D; Wu S; Huang L; Yang S; He D; Xiao X
Lung Cancer; 2006 Oct; 54(1):95-102. PubMed ID: 16890323
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer.
Ragazzi E; Pucciarelli S; Seraglia R; Molin L; Agostini M; Lise M; Traldi P; Nitti D
J Mass Spectrom; 2006 Dec; 41(12):1546-53. PubMed ID: 17117375
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
Zhao L; Wang H; Li J; Liu Y; Ding Y
J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
[TBL] [Abstract][Full Text] [Related]
20. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example.
Chang JT; Chen LC; Wei SY; Chen YJ; Wang HM; Liao CT; Chen IH; Cheng AJ
Clin Biochem; 2006 Dec; 39(12):1144-51. PubMed ID: 17014837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
